Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $46.7 million.

  • Prestige Consumer Healthcare's Net Income towards Common Stockholders fell 2348.93% to $46.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $186.5 million, marking a year-over-year decrease of 1282.35%. This contributed to the annual value of $214.6 million for FY2025, which is 251.55% up from last year.
  • As of Q4 2025, Prestige Consumer Healthcare's Net Income towards Common Stockholders stood at $46.7 million, which was down 2348.93% from $42.2 million recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Net Income towards Common Stockholders ranged from a high of $61.0 million in Q4 2024 and a low of -$240.6 million during Q1 2023
  • Its 5-year average for Net Income towards Common Stockholders is $35.9 million, with a median of $50.6 million in 2021.
  • In the last 5 years, Prestige Consumer Healthcare's Net Income towards Common Stockholders plummeted by 56183.62% in 2023 and then soared by 12056.02% in 2024.
  • Prestige Consumer Healthcare's Net Income towards Common Stockholders (Quarter) stood at $50.2 million in 2021, then rose by 3.46% to $52.0 million in 2022, then increased by 2.11% to $53.0 million in 2023, then increased by 15.05% to $61.0 million in 2024, then fell by 23.49% to $46.7 million in 2025.
  • Its last three reported values are $46.7 million in Q4 2025, $42.2 million for Q3 2025, and $47.5 million during Q2 2025.